Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 11677-11678 [2015-04465]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 42 / Wednesday, March 4, 2015 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Comparison and Validation of
Screening Tools for Substance Use
Among Pregnant Women, DP15–003,
initial review.
This document corrects a
notice that was published in the Federal
Register on February 18, 2015, Volume
80, Number 32, pages 8661. The time
and date should read as follows:
Time and Date: 11:00 a.m.–6:00 p.m.,
March 18, 2015 (Closed).
FOR FURTHER INFORMATION CONTACT: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F46, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
SUMMARY:
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–04467 Filed 3–3–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Epidemiologic Study of
Interstitial Cystitis, DP15–010, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 10:00 a.m.–6:30 p.m.,
March 26, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
VerDate Sep<11>2014
18:11 Mar 03, 2015
Jkt 235001
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Epidemiologic Study of
Interstitial Cystitis, DP15–010, initial
review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F–80, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–04468 Filed 3–3–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Times and Dates:
9:00 a.m.–4:30 p.m., Pacific Daylight
Time, March 25, 2015
9:00 a.m.–4:30 p.m., Pacific Daylight
Time, March 26, 2015
Public Comment Time and Date:
4:30 p.m.–5:30 p.m.,* Pacific Daylight
Time, March 25, 2015
* Please note that the public comment
period may end before the time
indicated, following the last call for
comments. Members of the public who
wish to provide public comments
should plan to attend the public
comment session at the start time listed.
Place: Red Lion Richland Hanford
House, 802 George Washington Way,
Richland, Washington 99352, Phone:
509–946–7611; Fax: 509–943–8564.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
11677
Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number is 1–866–659–0537 with a pass
code of 9933701.
Live Meeting Connection: https://
www.livemeeting.com/cc/cdc/join?id=
48H6RN&role=attend&pw=ABRWH&
i=i.ics; Meeting ID: 48H6RN; Entry
Code: ABRWH.
Status: Open to the public, limited
only by the space available. The meeting
space accommodates approximately 100
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2015.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters for Discussion: The agenda for
the Advisory Board meeting includes:
NIOSH Program Update; Department of
Labor Program Update; Department of
Energy Program Update; SEC Issues
E:\FR\FM\04MRN1.SGM
04MRN1
11678
Federal Register / Vol. 80, No. 42 / Wednesday, March 4, 2015 / Notices
Work Group Report on ‘‘Sufficient
Accuracy’’/Co-Worker Dose Modeling;
SEC Petitions Update; SEC petitions for:
Hanford (1984–1993; Richland,
Washington); Dow Chemical
Corporation (1947–1957; Pittsburgh,
California), Grand Junction Operations
Office (1975–2010; Grand Junction,
Colorado), Idaho National Laboratory
(1949–1970; Scoville, Idaho); an update
on the SEC petition review for the
Kansas City Plant (Kansas City,
Missouri); Review of the DuPont
Deepwater Works (Deepwater, New
Jersey) Site Profile; and Board Work
Sessions.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted to the contact person below
well in advance of the meeting. Any
written comments received will be
provided at the meeting in accordance
with the redaction policy provided
below.
Policy on Redaction of Board Meeting
Transcripts (Public Comment): (1) If a
person making a comment gives his or
her personal information, no attempt
will be made to redact the name;
however, NIOSH will redact other
personally identifiable information,
such as contact information, social
security numbers, case numbers, etc., of
the commenter.
(2) If an individual in making a
statement reveals personal information
(e.g., medical or employment
information) about themselves that
information will not usually be
redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator
will, however, review such revelations
in accordance with the Federal
Advisory Committee Act and if deemed
appropriate, will redact such
information.
(3) If a commenter reveals personal
information concerning a living third
party, that information will be reviewed
by the NIOSH FOIA coordinator, and
upon determination, if deemed
appropriated, such information will be
redacted, unless the disclosure is made
by the third party’s authorized
representative under the Energy
Employees Occupational Illness
Compensation Program Act (EEOICPA)
program.
(4) In general, information concerning
a deceased third party may be disclosed;
however, such information will be
redacted if (a) the disclosure is made by
an individual other than the survivor
claimant, a parent, spouse, or child, or
the authorized representative of the
deceased third party; (b) if it is unclear
whether the third party is living or
deceased; or (c) the information is
unrelated or irrelevant to the purpose of
the disclosure.
The Board will take reasonable steps
to ensure that individuals making
public comment are aware of the fact
that their comments (including their
name, if provided) will appear in a
transcript of the meeting posted on a
public Web site. Such reasonable steps
include: (a) A statement read at the start
of each public comment period stating
that transcripts will be posted and
names of speakers will not be redacted;
(b) A printed copy of the statement
mentioned in (a) above will be
displayed on the table where
individuals sign up to make public
comments; (c) A statement such as
outlined in (a) above will also appear
with the agenda for a Board Meeting
when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above
will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings.
Contact Person for More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road
NE., MS E–20, Atlanta, Georgia 30333,
telephone: (513) 533–6800, toll free: 1–
800–CDC–INFO, email: dcas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–04465 Filed 3–3–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects
Title: Low Income Home Energy
Assistance Program (LIHEAP) Carryover
and Re-allotment Report.
OMB No.: 0970–0106.
Description: The LIHEAP statute and
regulations require LIHEAP grantees to
report certain information to HHS
concerning funds forwarded and funds
subject to reallotment. The 1994
reauthorization of the LIHEAP statute,
the Human Service Amendments of
1994 (Pub. L. 103–252), requires that the
carryover and reallotment report for one
fiscal year be submitted to HHS by the
grantee before the Allotment for the next
fiscal year may be awarded.
We are requesting no changes in the
collection of data with the Carryover
and Reallotment Report For FY 20__, a
form for the collection of data, and the
Simplified Instructions for Timely
Obligations of FY 20__ LIHEAP Funds
and Reporting Funds For Carryover and
Reallotment. The form clarifies the
information being requested and
ensures the submission of all the
required information. The form
facilitates our response to numerous
queries each year concerning the
amounts of obligated funds. Use of the
form is voluntary. Grantees have the
option to use another format.
Respondents: State, Local or Tribal
Government.
ANNUAL BURDEN ESTIMATES
Number of
respondents
mstockstill on DSK4VPTVN1PROD with NOTICES
Instrument
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
Carryover & Reallotment .................................................................................
210
1
3
630
Estimated Total Annual Burden Hours .....................................................
........................
........................
........................
630
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
VerDate Sep<11>2014
18:11 Mar 03, 2015
Jkt 235001
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
information collection described above.
Copies of the proposed collection of
information can be obtained and
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 80, Number 42 (Wednesday, March 4, 2015)]
[Notices]
[Pages 11677-11678]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-04465]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Times and Dates:
9:00 a.m.-4:30 p.m., Pacific Daylight Time, March 25, 2015
9:00 a.m.-4:30 p.m., Pacific Daylight Time, March 26, 2015
Public Comment Time and Date:
4:30 p.m.-5:30 p.m.,* Pacific Daylight Time, March 25, 2015
* Please note that the public comment period may end before the
time indicated, following the last call for comments. Members of the
public who wish to provide public comments should plan to attend the
public comment session at the start time listed.
Place: Red Lion Richland Hanford House, 802 George Washington Way,
Richland, Washington 99352, Phone: 509-946-7611; Fax: 509-943-8564.
Audio Conference Call via FTS Conferencing. The USA toll-free, dial-in
number is 1-866-659-0537 with a pass code of 9933701.
Live Meeting Connection: https://www.livemeeting.com/cc/cdc/join?id=48H6RN&role=attend&pw=ABRWH&i=i.ics; Meeting ID: 48H6RN; Entry
Code: ABRWH.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 100 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines which have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule, advice on methods of dose reconstruction which have
also been promulgated by HHS as a final rule, advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program, and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2015.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advising the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters for Discussion: The agenda for the Advisory Board meeting
includes: NIOSH Program Update; Department of Labor Program Update;
Department of Energy Program Update; SEC Issues
[[Page 11678]]
Work Group Report on ``Sufficient Accuracy''/Co-Worker Dose Modeling;
SEC Petitions Update; SEC petitions for: Hanford (1984-1993; Richland,
Washington); Dow Chemical Corporation (1947-1957; Pittsburgh,
California), Grand Junction Operations Office (1975-2010; Grand
Junction, Colorado), Idaho National Laboratory (1949-1970; Scoville,
Idaho); an update on the SEC petition review for the Kansas City Plant
(Kansas City, Missouri); Review of the DuPont Deepwater Works
(Deepwater, New Jersey) Site Profile; and Board Work Sessions.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted to the contact person below well in advance of the meeting.
Any written comments received will be provided at the meeting in
accordance with the redaction policy provided below.
Policy on Redaction of Board Meeting Transcripts (Public Comment):
(1) If a person making a comment gives his or her personal information,
no attempt will be made to redact the name; however, NIOSH will redact
other personally identifiable information, such as contact information,
social security numbers, case numbers, etc., of the commenter.
(2) If an individual in making a statement reveals personal
information (e.g., medical or employment information) about themselves
that information will not usually be redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator will, however, review such
revelations in accordance with the Federal Advisory Committee Act and
if deemed appropriate, will redact such information.
(3) If a commenter reveals personal information concerning a living
third party, that information will be reviewed by the NIOSH FOIA
coordinator, and upon determination, if deemed appropriated, such
information will be redacted, unless the disclosure is made by the
third party's authorized representative under the Energy Employees
Occupational Illness Compensation Program Act (EEOICPA) program.
(4) In general, information concerning a deceased third party may
be disclosed; however, such information will be redacted if (a) the
disclosure is made by an individual other than the survivor claimant, a
parent, spouse, or child, or the authorized representative of the
deceased third party; (b) if it is unclear whether the third party is
living or deceased; or (c) the information is unrelated or irrelevant
to the purpose of the disclosure.
The Board will take reasonable steps to ensure that individuals
making public comment are aware of the fact that their comments
(including their name, if provided) will appear in a transcript of the
meeting posted on a public Web site. Such reasonable steps include: (a)
A statement read at the start of each public comment period stating
that transcripts will be posted and names of speakers will not be
redacted; (b) A printed copy of the statement mentioned in (a) above
will be displayed on the table where individuals sign up to make public
comments; (c) A statement such as outlined in (a) above will also
appear with the agenda for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in (a) above will appear in the
Federal Register Notice that announces Board and Subcommittee meetings.
Contact Person for More Information: Theodore Katz, Designated
Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E-20, Atlanta,
Georgia 30333, telephone: (513) 533-6800, toll free: 1-800-CDC-INFO,
email: dcas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-04465 Filed 3-3-15; 8:45 am]
BILLING CODE 4163-18-P
